62 results
Page 2 of 4
8-K
EX-99.1
kwqon ogks71umczh
13 Oct 20
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
7:40am
8-K
EX-99.1
hsqnksytl8eek v7
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
EX-99.2
dpmr6uvzy
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
EX-1.1
sqy48u3tji jx8h
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
EX-1.2
p1wcy4i
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
424B5
cukq26f250o34s1sxkwf
19 May 20
Prospectus supplement for primary offering
5:11pm
424B5
wzym5lof uo
19 May 20
Prospectus supplement for primary offering
5:08pm
FWP
sqdfjfbr
19 May 20
Free writing prospectus
6:06am
FWP
qkj2vm
18 May 20
Free writing prospectus
5:02pm
424B5
1kadcwa
18 May 20
Prospectus supplement for primary offering
4:16pm
424B5
qx7lb
18 May 20
Prospectus supplement for primary offering
4:11pm
8-K
EX-10.1
q4eqbn5ympkeu41u
3 May 19
Gossamer Bio Secures Debt Facility for Up to $150 Million
4:00pm
10-K
cghz aedfss
22 Mar 19
Annual report
4:45pm
424B4
z7orq248gur9 jdv
8 Feb 19
Prospectus supplement with pricing info
4:40pm
FWP
bvfn9k8ei1fd
30 Jan 19
Free writing prospectus
5:29pm